Compare NSRX & BHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSRX | BHV |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1M | 36.9M |
| IPO Year | 2024 | 2002 |
| Metric | NSRX | BHV |
|---|---|---|
| Price | $2.87 | $12.42 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 15.0K | 3.7K |
| Earning Date | 08-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $10.04 |
| 52 Week High | $9.50 | $15.15 |
| Indicator | NSRX | BHV |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 51.55 |
| Support Level | $2.98 | $11.08 |
| Resistance Level | $3.61 | $12.99 |
| Average True Range (ATR) | 0.30 | 0.34 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 26.14 | 52.98 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective of the fund is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.